Trial Profile
A Phase I/II Open-label Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 12 Jan 2018
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Sensorineural hearing loss
- Focus Therapeutic Use
- 29 Sep 2015 New trial record